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Abstract
Hypothalamic hamartoma (HH) is usually associated with 
refractory epilepsy, cognitive impairment, and behavioral 
disturbance. There is now increasing evidence that HH 
can be treated effectively with a variety of neurosurgical 
approaches. Treatment options for intractable gelastic 
seizure in HH patients include direct open surgery 
with craniotomy, endoscopic surgery, radiosurgery 
with gamma knife and stereotactic radiofrequency ther-
mocoagulation. Selection of treatment modalities depends 
on type and size of the HH and the surgeon’s preference. 
Two surgical techniques, resection and disconnection, had 
been described with favorable outcomes. Pretreatment 
evaluation, patient selection, surgical techniques, com-
plications, and possible selection of treatment are 
discussed. 
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surgery; Radiosurgery; Stereotactic radiofrequency 
ablation
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Neuronavigation-assisted neuroendoscopic 
surgery has been remarkably advancing. Furthermore 
high definition video recording system becomes 
its basic visualization system to facilitate the diffe-
rentiation between normal tissue and abnormal tissue 
of hypothalamic hamartomas. Neuroendoscopic 
disconnection has been suggested to reduce the Gelastic 
seizure by the isolation of hypothalamic hamartomas 
(HHs) from surrounding structures. We are getting more 
powerful tools for performing sophisticated endoscopic 
disconnection surgery. Neuroendoscopic disconnection 
surgery used to be an optional surgery, but it becomes 
the first choice of surgery for HH with Gelastic seizure. 
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INTRODUCTION
The compulsive bursts of laughter were first introduced 
at 1873. Since Gumpert et al[1] described the feature 
of gelastic seizure (GS) Gascon et al[2] suggested the 
diagnostic criteria of gelastic epilepsy. Gelastic seizures 
represent the most common clinical expression of 
epilepsy and cause the patient to present sudden, 
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brief, uncontrollable attacks of laughter. These gelastic 
attacks progress as the patient ages, and other types 
of seizure, cognitive deterioration, and behavioral 
problems appear, frequently developing late in first 
decade of life, together with drop attacks and other 
secondary generalized epilepsy symptoms[3]. It has 
been demonstrated that epileptic focus originates 
from the hamartoma and from neocortical foci strictly 
related to Hypothalamic hamartomas (HHs)[4,5]. HHs 
are rare non-neoplastic congenital lesions of the inferior 
hypothalamus and consist of an abnormal mixture of 
neuronal and glial tissue. They issue from the floor 
of the third ventricle, tuber cinereum, or mammillary 
bodies. Hypothalamic hamartoma can be classified as 
sessile or pedunculated, depending on the width of 
their attachment to hypothalamus. Various symptoms 
have been associated with the sessile type of HH, 
including refractory epilepsy, central precocious puberty, 
intellectual impairment, and behavioral problems[6]. 
On the other hand, HHs causing isosexual precocious 
puberty are more likely to be pedunculated lesions 
that “hang” below the tuber cinereum. Close anatomic 
connections between HH and diencephalic hypothalamic 
structures also explain the autonomic, mainly sym-
pathetic, symptoms and hormonal changes that 
accompanying GS[7-9]. GS appears in early childhood 
and quickly becomes refractory to medical treatment. 
The severity of the syndrome might depend, at least 
in part, on the size (small vs large), localization (tuber 
cinereum vs mamillary bodies), type of attachment 
(pedunculate vs sessile) and degree of hypothalamic 
displacement of the HH (lacking vs marked)[10-13]. Since 
Paillas et al[14] reported successful seizure outcome 
after resection of HHs in some patients in 1969, surgical 
intervention for these lesions has been attempted with 
variable seizure outcome[14]. Since 2000 the understanding 
and management of HH has increased dramatically 
especially in terms of intractable epilepsy. The state 
of the art of magnetic resonance imaging (MRI) and 
neuronavigation have developed synchronously by the 
turn of the millennium. Eventually we can have the tools 
for the safe and effective treatment of lesions in critical 
areas of the brain and without physically demonstrable 
borders between the offending lesion and critical areas 
of the brain such as the hypothalamus[15].
Focal (frontal or temporal) resections have never 
resolved GS, even when associated with depth 
electrode studies[16-19], whereas surgical and gamma-
knife ablation, and radiofrequency coagulation of HH 
resulted in good seizure control[4,18-25]. Four surgical 
treatments have been introduced to treat HH: direct 
open surgery with craniotomy, endoscopic surgery, 
radiosurgery with gamma knife (GKS), and stereotactic 
radiofrequency thermocoagulation. Two techniques 
for HH surgery are used: resection or disconnection of 
hamartoma. The concept of disconnection had been 
introduced by Delalande et al[26] and it showed dramatic 
improvement in the patient. The technique disconnects 
the connecting tract between the hamartoma and the 
surrounding normal tissue.
Between 1990 and 2000, case reports on the 
successful surgical management of HH began to surface. 
These reports presumably reflected the increasing 
availability of contemporary imaging techniques. The 
first computed tomography (CT) scanner was installed in 
the United States in 1973[15]. A neurosurgeon removing 
or disconnecting an HH sees tissue that looks just 
like normal brain. The ability to identify the HH-brain 
interface depends on the subtle differences in signal 
intensity seen on MRI and shown by the navigation 
system. The surgical view is through the microscope, 
utilizing the endoscope or stereotactic equipment for 
Gamma Knife or the implantation of radiofrequency 
electrodes. The surgical approach to the lesion should 
be tailored to each case. No single approach is best for 
every patient.
Presurgical evaluation includes routine electro-
encephalographic (EEG) monitoring and video-EEG 
monitoring with scalp electrodes, interictal and ictal 
99m-Tc hexamethylprophyleneamine oxime single 
photon emission CT, MRI, neuropsychological evaluation, 
ophthalmological assessments with perimetry, and 
endocrinological investigations. The dimensions of the 
HHs and the anatomy surrounding the tuber cinereum 
can be seen clearly by high-resolution coronal and 
sagittal T1-weighted MRI. Endocrine assessment 
includes measurement of basal gonadotrophin and 
growth hormone levels, thyroid function, prolactin level, 
and cortisol reserve with glucagon stimulation. Deep 
electrode insertion into the HH with EEG monitoring 
may be necessary in some cases. Intractable seizure 
of the predominant gelastic type is an indication for 
surgical treatment. Gelastic seizures refractory to 
medication, neurobehavioral deterioration and direct or 
indirect evidence of hypothalamic seizure origin, and the 
absence of a cortical lesion on MRI are recommended 
for surgical treatment. The potential risks to memory, 
endocrine function, behavior, and vision have to be 
explained to the parents[25,27,28].
Endoscopic surgery
In patients with gelastic epilepsy-HH syndrome, the 
hamartoma is usually sessile; pedunculated HH is an 
occasional finding or may be related to endocrinological 
disturbances and/or to visual impairment[13,29]. Choi 
et al[27] suggested the modified classification of sessile 
HH, which was introduced by Delalande et al[26] 
(Figure 1). Small HHs (< 20 mm) were classified as 
midline (Type Ⅰ), lateral (Type Ⅱ), or intraventricular 
(Type Ⅲ) according to the location of the HH relative 
to the hypothalamus and third ventricle. A large 
hamartoma (> 20 mm) was de fined as giant HH 
(Type Ⅳ). Delalande et al[26] first reported on the use 
of endoscopic disconnection only for intraventricular 
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type of hamartoma (Type Ⅲ) in 2003[3]. They also did 
endoscopic procedures in addition to conventional open 
surgery to treat other types of hamartoma. However, 
Choi et al[27] had tried endoscopic disconnection for 
Type Ⅰ, Type Ⅱ, and Type Ⅲ as the primary option 
of treatment and also used endoscopic surgery as an 
additional procedure for Type Ⅳ HH. Since Choi et al[27] 
suggested this approach Rekate et al[30] have found 
that most HHs within the third ventricle are excellent 
candidates for this type of excision[27,31]. Even the 
seizure returns redo endoscopic disconnection can be an 
effective rescue. Pati et al[32] reported their experience 
of repeat HHs surgery that they did re-endoscopic 
surgery for 8 of 21 patients and 50% of success rate. 
Shim et al[25] (the authors’ group) reported their 
experience with endoscopic disconnection in 11 patients 
in 2008. Six of 11 patients were seizure-free (Engel’s class 
1) immediately after surgery. Improvement in behavior 
was also noted in these patients after 2 mo. Outcome 
in three patients was class 2. In two other complicated 
cases which were treated with gamma knife surgery 
previously, seizure control was not satisfactory (class 
3 or 4), but most cases showed complete resolution or 
a reduction of gelastic seizures. Procaccini et al[33] (the 
Delalande group) reported the results of 13 patients 
treated with frameless stereotactic endoscopic surgery 
in 2006[33]. Seizure-free recovery (Engel class 1) was 
achieved in 54% of the patients, and 46% of the 
patients showed improvement (Engel class 3). For the 
intraventricular type of HH, 90% of patients became 
seizure-free postoperatively. Ng et al[31] reported their 
experience with endoscopic removal in 44 patients 
based on early results. Ideal candidates for this surgery 
have been those with a lesion smaller than 1.5 cm 
in diameter. Patients with larger lesions also may be 
candidates as long as 6 mm of clearance is present 
to the top of the third ventricle. By the advance of 
high resolution of neuroimaging and technology of 
neuronavigation system the size of HHs might not 
be a critical point of decision for endoscopic surgery 
any more even though most of HHs patients have 
small ventricle[25,34]. In the Ng et al[31]’s report among 
37 patients who underwent endoscopic resection 18 
patients (48.6%) were seizure free at last follow-
up (median 21 mo, range 13-28 mo). Seizures were 
reduced in 34 of 37 patients (91.9%)[30]. For giant HHs 
staged endoscopic disconnection becomes a one of the 
choice of treatment by the advent of neuronavigational 
neuroendoscope with high definition visualization 
system. The entry point, trajectory, and entry for small 
ventricle can be guided perfectly by this system. High 
definition visualization system can show a distinct cleft 
or indentation, the border of the HH attachment to the 
hypothalamus[25].
In Rekate’s series, early complications occurred in 
11 (25%) of 44 patients but resolved within 3 mo in 
all but three patients (6.8%), including one patient 
with postoperative hemiparesis and two patients with 
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Type Ⅰ: Midline                                                                        Type Ⅱ: Lateral
Type Ⅲ: Intraventricular                                                                  Type Ⅳ: Giant
Figure 1  Classification of sessile hypothalamic hamartoma. (Modified by Choi et al[27] from that proposed by Delalande et al[26]). The hypothalamic hamartomas 
(HHs) were divided into four categories based on MRI findings demonstrating the relationship between the hamartoma and hypothalamus or the third ventricle. A large 
hamartoma (> 20 mm) was defined as a giant HH (Type Ⅳ). Small HHs (< 20 mm) were classified as midline (Type Ⅰ), lateral (Type Ⅱ), and intraventricular (Type Ⅲ) 
according to their relative location to the third ventricle. MRI: Magnetic resonance imaging.
Shim KW et al . How would we deal with hypothalamic hamartomas?
of the mass that lay within the third ventricle, even after 
the lamina terminalis was opened[15]. The exposure is 
usually inadequate, and critical tissue borders are not 
readily apparent. Seizures were cured or reduced in 
52% of patients undergoing approaches from below[6]. 
Delalande et al[26] introduced disconnecting surgical 
treatment for extraventricular HH in 2003. Dramatic 
improvement in 53% of those who underwent the 
procedure using pterional approach was reported. 
Two of 14 disconnection surgeries showed ischemic 
complications. 
Rosenfeld et al[38] reported their experience with 
the transcallosal interforniceal approach in 2000[38,39]. 
Complete or nearly complete resection of HHs can be 
safely achieved via this approach with the possibility of 
seizure freedom and neurobehavioral improvement[39-41]. 
This approach can be used alone to treat large type Ⅱ 
and Ⅲ lesions. Many type Ⅳ lesions require a staged 
approach. If the lesion is entirely medial to the line 
of sight down the wall of each hypothalamus, then a 
large type Ⅲ or Ⅳ lesion can be disconnected during 1 
operation[28,36]. Wait et al[36] described this approach at 
length.
Rosenfeld et al[21] reported complete or near total 
resection (> 95%) of HH in about 62% of the patients 
and 75%-95% resection was possible in about 24% of 
the patients. Harvey et al[42] reported that transcallosal 
resection of HH was effective treatment for intractable 
epilepsy, with 54%-76% of the patients being seizure-
free or having a > 90% reduction in seizures. There 
also were improvements in behavior and cognition 
in 65%-88%. With univariate analysis, the likelihood 
of a seizure-free outcome correlated with younger 
age, shorter lifetime duration of epilepsy, smaller 
volume of HH, and total HH resection[42]. Postoperative 
complications were stroke, short-term memory 
disturbance, weight gain, diabetes insipidus, and other 
endocrine disturbances. Stroke is probably the result of 
injury of perforating vessels surrounding HH and short-
term memory disturbance is due to surgical trauma of 
the septal, forniceal, or mammillary body. Five of the 37 
patients (13.5%) treated endoscopically experienced 
immediate short-term memory loss, compared with 15 
of 26 transcallosal patients (57.7%; P = 0.7281, Fishers 
exact test) in Ng et al[31]’s series[30] and permanent short 
term memory loss in 3 patients (8.2%) in endoscopic 
surgery group. Endocrinological morbidity is likely due 
to injury of neurovascular structure or pituitary stalk. 
Injuries to the optic tract and cranial nerve were rare 
with the transcallosal approach, but these injuries have 
been reported more with the traditional pterional and 
subfrontal approaches[43]. If the laterobasal approach 
is desired the orbitozygomatic approach should be 
preferred. Orbitozygomatic approach provides minimal 
brain retraction, maximum working space and light, and 
more favorable approach angle to HHs[44,45]. For lesions 
with ipsilateral attachment, the supraorbital eyebrow 
short-term memory loss. Early complications included 
transient short-term memory loss, weight gain, thalamic 
infarction with memory loss, and hemiparesis[31,35]. 
Five of the 37 patients (13.5%) treated endoscopically 
experienced immediate short-term memory loss and 
permanent short term memory loss in 3 patients (8.2%) 
in endoscopic surgery group in Ng et al[31]’s series[30]. 
Choi et al[27] observed postoperative disconnection-
like syndrome in three patients, which included mental 
dullness, verbal anomia, unilateral tactile anomia, and 
lack of somesthetic transfer. This disconnection-like 
syndrome disappeared spontaneously within 10 d. Even 
with multiple staging endoscopic disconnection the 
morbidity has been acceptable[25,32,36]. For minimizing 
complications proper trajectory directly to HHs, no 
anterior wiping motion of endoscope, not breaching 
arachnoid or pia mater keeping within third ventricle, 
and keep disconnection margin straight are very 
essential instructions. If the piarachnoid membrane was 
breached unilateral thalamic infarction can be resulted in 
about 30%[30]. However, many of these patients are so 
clinically and socially impaired that clinically significant 
damage to a mammillary body or fornix would not be 
evident. For this reason, it is reasonable to be more 
aggressive in pursuing resection or disconnection and 
in tolerating damage to relieve epilepsy in severely 
affected patients[36]. 
Although not all lesions are possibly deal with the 
endoscopic disconnection the feasibility of successful 
disconnection depends on a number of factors, including 
the plane and extent of attachment of the HH to the 
hypothalamus[37]. Some large lesions may require a 
multistep approach in which several disconnective 
procedures are used, or a combination of microsurgical 
resection and endoscopic disconnection. Larger lesion 
(> 15 mm) has been reported as an invincible with 
endoscopic disconnection. If you want to remove the 
HH completely, it will be nearly impossible with an HH 
that is over 1.5 cm. However, as we have reported, 
disconnection of the lesion from the brain is possible. 
The size of the lesion is not a major problem in 
disconnecting the lesion from the brain[25].
Open surgery with craniotomy
Multiple surgical approaches to the resection of HH 
have been described. Transbasal approaches with 
variations, such as the standard pterional approach, 
extended pterional approach with orbitotomy, and 
subfrontal approach, were reported but unfortunately 
many of these techniques were associated with high 
complication rates, including infarction of the internal 
capsule and thalamus, cranial nerve palsy (third nerve, 
olfactory nerve, and optic nerve), endocrinopathy, 
and memory loss. There also were difficulties in 
completely excising the lesion which extended into 
third ventricle[15,25,28]. Through these approaches, it was 
difficult or impossible to remove or disconnect the part 
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approach may be sufficient[36]. Transcallosal anterior 
interforniceal approach used to resect HHs seems to be 
associated with a higher risk of postoperative memory 
difficulty than are approaches from below. The risk of 
endocrinological and hypothalamic damage may be 
higher, evidenced by diabetes insipidus, hypothyroidism, 
changes in appetite, decreased energy, and lethargy. This 
risk may reflect the potential for bilateral hypothalamic 
damage when approaching from above and midline 
compared with laterobasal access[40]. Potential long-term 
endocrinological deficits consist of permanent diabetes 
insipidus and hypothyroidism, which reported exclusively 
in patients after transcallosal anterior interforniceal 
approach approaches[40]. It is tremendously important 
to identify and follow the piarachnoid membrane 360° 
to disconnect HHs completely and avoid injury to critical 
structures, optic tract and perforating arteries of the 
basilar and posterior cerebral arteries. The overall rate of 
major permanent hypothalamic complications appeared 
to be slightly lower for the orbitozygomatic osteotomy 
group[40]. However there is a report for good cognitive 
outcomes with proper surgical resection for HHs of 
younger patients with relatively normal intelligence prior 
to surgery and shorter duration of epilepsy in case of no 
surgical complication[46].
Radiosurgery
Destruction of the HH lesion using focused ionizing 
radiation (gamma knife) is an attractive approach 
that does not require invasive surgery. Although a 
delayed (4-6 mo) response to gamma knife treatment 
is expected, early results suggest variable outcomes. 
Régis et al[47] reported excellent early seizure response. 
However, results in terms of long-term seizure freedom 
are not clear. The treatment goal of radiosurgery for HH 
is to deliver doses high enough to affect epileptogenesis 
without exceeding the tolerance of nearby critical 
structures. Modern radiosurgical devices such as 
Gamma Knife (Elekta AG), Cyber Knife (Accuray Inc.), 
and Novalis (BrainLab AG) can deliver conformal high-
dose radiation with steep gradients providing a chance 
to achieve seizure freedom without hypothalamic or 
cranial nerve damage. Achievement of an excellent 
outcome following radiosurgery is related to the dose 
delivered. Régis et al[47] observed that four patients 
who received a peripheral dose of 18 Gy with the 
Gamma Knife became seizure free. Careful treatment 
planning and very tight dose distribution are essential 
to delivering similar doses without injuring the optic 
chiasm, optic tracts, pituitary stalk, fornices, mammillary 
bodies, and hypothalamic nuclei. The mean size of HH 
in a large series of radiosurgery was 19 mm in diameter, 
but radiosurgery can be accomplished in lesions smaller 
than 30 mm by using steep dose gradients around the 
target[47], while the size for ideal surgical candidate was 
reported less than 16 mm[48]. No serious complication 
has been reported with radiosurgery but temporary 
worsening of seizures can be seen as early as 2 mo 
after the procedure. Successful radiosurgical treatment 
of epileptogenic HHs was first reported in 1998 by 
Arita et al[22]. Régis et al[47] found a clear correlation 
between dose and efficacy; the marginal dose was 
> 17 Gy in all patients in whom seizure freedom was 
achieved and all patients who received < 13 Gy showed 
incomplete seizure control. Updated outcome of a large 
series (over 60 patients) by Régis et al[47] reported that 
thirty-one patients were evaluated for at least 3 years 
after radiosurgery; of these, satisfactory follow-up was 
available in 27. Only 10 (37%) of these 27 patients 
achieved seizure freedom; 6 others (22%) experienced 
a significant decrease in frequency of seizures[47]. The 
median prescribed marginal dose was 17 Gy (range 
13-26 Gy). The authors judiciously used a beam 
blocking strategy to reduce the dose delivered to critical 
surrounding structures. However, in the other series 
in which doses ranging from 12 to 14 Gy were used, 
outcome of seizure control was variable[25,49]. 
Several other groups have reported their experience 
with GKS for treating intractable epilepsy related to 
HHs[25,50-56]. These studies demonstrate that GKS is 
an effective treatment modality for selected patients 
with HH-associated epilepsy. However, it is important 
to remember that, similar to the complications of 
microsurgical resection of the HH, radiosurgery can 
result in permanent neurological sequelae[57,58]. Also, 
there seems to be a dose-dependent response in 
which improved seizure control rates are attained with 
marginal doses > 16 Gy[59]. However, one of the main 
disadvantages is that clinical response can be very slow; 
the patient remains exposed to the risks of persistent 
seizures for up to 2 years after the radiosurgical 
procedure[60].
Stereotactic radiofrequency ablation
In 1999 Fukuda et al[61] reported on a single patient 
with HH treated by stereotactic radiofrequency 
thermocoagulation in the course of exploration with a 
depth electrode implanted within the lesion. Gelastic 
seizures ceased postoperatively and tonic seizures 
disappeared 4 mo later. Finally, this patient became 
seizure free within 14 mo. Kameyama et al[62] and 
Homma et al[63] reviewed results from 25 consecutive 
patients with HH and gelastic seizures who were 
treated with radiofrequency thermocoagulation. They 
divided HHs into 3 types based on coronal MRI findings: 
intrahypothalamic, parahypothalamic, and mixed type. 
Complete seizure freedom was seen in 19 (76%) of 25 
patients over a mean follow-up of 2.3 years. Transient 
postoperative complications included hyperthermia, 
hyperphagia, hyponatremia, Horner syndrome, and 
short-term memory problems. Complications included 
low-grade fever (4 patients) and hyperphagia (2 
patients) and occurred transiently as local hypothalamic 
symptoms. These transient symptoms resolved within 
69 March 28, 2015|Volume 5|Issue 1|WJSP|www.wjgnet.com
Shim KW et al . How would we deal with hypothalamic hamartomas?
1 wk after surgery after perifocal edema disappeared; 
no permanent complications were noted. All 10 patients 
who had behavior disturbances preoperatively showed 
complete resolution of their behavioral abnormalities 
following radiofrequency ablation.
This procedure seems to be effective for a small 
hamartoma but a long-term study of a large series 
will be necessary to con firm the efficacy and safety of 
this treatment[63-65]. The results with stereotactic radio-
frequency ablation, unlike with stereotactic radiosurgery, 
can be seen immediately following the procedure. 
However, drawbacks of the technique include inexact 
volume of tissue ablation and the need for multiple 
trajectories to treat larger hamartomas, thereby adding 
to the risk of injury to the surrounding neurovascular 
structures compared with a single pass[25].
Neuromodulation
Deep brain stimulation and vagal nerve stimulation have 
tried to override epileptogenic activity from HHs[40,66-69]. 
No definite change in her overall seizure frequency 
(complex partial and gelastic seizures) as well as no 
behavioral, endocrinological, or neurological side effects 
has been reported. These palliative techniques are not 
effective in controlling gelastic seizures, and therefore 
have a very limited role in the treatment of patients 
with HH-associated gelastic seizures. Certainly, further 
work needs to be done to determine the role of these 
techniques in the treatment of epilepsy related to HHs.
Selection of the neurosurgical procedure to perform 
depends on the surgeon’s preference and experience, 
but reasonable approaches can be selected according 
to the location, shape, and size of the HH. Possible 
treatment selections according to subdivided types 
of hypothalamic hamartoma are given in Figure 2, 
although treatment options can be different depending 
on the viewpoint of the surgeon[28].
No single approach is the best approach or is 
appropriate in all cases (Table 1). Adequate treatment 
requires individualization of the approach based on 
a patient’s age and condition, on the anatomy of the 
HH, and on the surgeon’s experience. It is becoming 
increasingly clear that a 1-stage approach to all HHs 
is probably inappropriate[36]. About 16% of patients 
required more than one procedure. By the nature and 
pathophysiology of HHs the complete disconnection 
from the surrounding structure and tracts which spread 
out its epileptogenic discharge to frontotemporal region 
will be enough to achieve the appropriate control of 
accompanying problems. If an HH can be disconnected 
completely from the hypothalamus, resection may not 
be necessary to eliminate seizures[4,30].
It is important to remember that a HH cannot 
be distinguished from normal hypothalamus under 
microsurgical view. Only the abnormal anatomy that it 
forms allows the surgeon to determine where to stop 
resection. Careful evaluation of the patient’s preoperative 
MRI study and use of intraoperative stereotactic guidance 
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Table 1  Advantages and disadvantages between modalities
Treatment modality Advantages Disadvantages
Endoscopic surgery Minimally invasive Multiple approaches for large HHs
Low possibility to injure adjacent critical structures Dependent on surgeon's experience
Critical tissue borders are readily apparent
Relatively low complication even with Re-do surgery
Relatively easy approach to the intrathird ventricular lesion
Open surgery with craniotomy
   The standard pterional approach The risk of endocrinological and hypothalamic damage may 
be lower than transcallosal approach
High complication rates
Difficulties in completely excising the lesion 
which extended into third ventricle
Inadequate exposure is usual 
Critical tissue borders are not readily apparent
   Transcallosal interforniceal approach Complete or nearly complete resection of HHs can be safely 
achieved via this approach 
Surgical trauma to the septal, forniceal, or 
mammillary body
Can be used alone to treat large HHs The risk of endocrinological and hypothalamic 
damage may be higher
Injuries to the optic tract and cranial nerve were rare
Radiosurgery Does not require invasive surgery Delayed (4-6 mo) response
Provide a chance to achieve seizure freedom without 
hypothalamic or cranial nerve damage
Long-term seizure freedom are not clear
Lesions smaller than 30 mm 
Dose-dependent response 
Stereotactic radiofrequency ablation Effective for a small hamartoma Effective for a small hamartoma 
Immediate response Inexact volume of tissue ablation 
Multiple trajectories to treat larger hamartomas
Neuromodulation No behavioral, endocrinological, or neurological side effects 
has been reported
No definite change in overall seizure frequency 
HHs: Hypothalamic hamartomas.
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Type Ⅰ midline 
Type of hamartoma                                                                                                                  Possible selection of treatment
1 Radiosurgery
2 Endoscopic surgery
3 Stereotactic radiofrequency ablation
Type Ⅱ lateral
Type ⅡA partially intraventricular 1 Radiosurgery
2 Endoscopic surgery
3 Stereotactic radiofrequency ablation
Type ⅡB totally extraventricular 1 Radiosurgery
2 Stereotaqctic radiolrequency ablation
3 Open craniotomy; pterional approach
Type ⅡC mixed 1 Endoscopic surgery + open craniotomy pterional
2 Staged radiosurgery
Type Ⅲ intraventricular
Type ⅢA midline intraventricular 1 Endoscopic surgery
2 Open craniotomy; transcallosal approach
1 Endoscopic surgery
2 Open craniotomy; transcallosal approach
Type ⅢB lateral intraventricular
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help clarify the aforementioned limits of resection[36].
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Figure 2  Possible treatments for subdivided types of hypothalamic hamartoma[28]. (Modification from Delalande et al[26]’s and Choi et al[27]’s classification).
Shim KW et al . How would we deal with hypothalamic hamartomas?
DS. Endoscopic disconnection for hypothalamic hamartoma with 
intractable seizure. Report of four cases. J Neurosurg 2004; 100: 
506-511 [PMID: 15287464 DOI: 10.3171/ped.2004.100.5.0506]
28 Choi JU, Kim DS. Treatment modalities for intractable epilepsy 
in hypothalamic hamartoma. Adv Tech Stand Neurosurg 2012; 39: 
117-130 [PMID: 23250839 DOI: 10.1007/978-3-7091-1360-8_5]
29 Boyko OB, Curnes JT, Oakes WJ, Burger PC. Hamartomas of 
the tuber cinereum: CT, MR, and pathologic findings. AJNR Am J 
Neuroradiol 1991; 12: 309-314 [PMID: 1902033]
30 Rekate HL, Feiz-Erfan I, Ng YT, Gonzalez LF, Kerrigan JF. 
Endoscopic surgery for hypothalamic hamartomas causing 
medically refractory gelastic epilepsy. Childs Nerv Syst 2006; 22: 
874-880 [PMID: 16770620 DOI: 10.1007/s00381-006-0125-4]
31 Ng YT, Rekate HL, Prenger EC, Wang NC, Chung SS, Feiz-Erfan I, 
Johnsonbaugh RE, Varland MR, Kerrigan JF. Endoscopic resection 
of hypothalamic hamartomas for refractory symptomatic epilepsy. 
Neurology 2008; 70: 1543-1548 [PMID: 18427070]
32 Pati S, Abla AA, Rekate HL, Ng YT. Repeat surgery for hypo-
thalamic hamartoma in refractory epilepsy. Neurosurg Focus 2011; 
30: E3 [PMID: 21374831]
33 Procaccini E, Dorfmüller G, Fohlen M, Bulteau C, Delalande O. 
Surgical management of hypothalamic hamartomas with epilepsy: 
the stereoendoscopic approach. Neurosurgery 2006; 59: ONS336-
ONS344; discussion ONS344-ONS346 [PMID: 17041502 DOI: 
10.1227/01.NEU.0000233900.06146.72]
34 Ito E, Fujii M, Hayashi Y, Zhengang J, Nagatani T, Saito K, Kishida 
Y, Mori K, Wakabayashi T. Magnetically guided 3-dimensional 
virtual neuronavigation for neuroendoscopic surgery: technique and 
clinical experience. Neurosurgery 2010; 66: 342-353; discussion 
353 [PMID: 20489524 DOI: 10.1227/01.NEU.0000369659.19479.
AF]
35 Lekovic GP, Gonzalez LF, Feiz-Erfan I, Rekate HL. Endoscopic 
resection of hypothalamic hamartoma using a novel variable 
aspiration tissue resector. Neurosurgery 2006; 58: ONS166-ONS169; 
discussion ONS166-ONS169 [PMID: 16543875 DOI: 10.1227/01.
NEU.0000193512.87279.69]
36 Wait SD, Abla AA, Killory BD, Nakaji P, Rekate HL. Surgical 
approaches to hypothalamic hamartomas. Neurosurg Focus 2011; 
30: E2 [PMID: 21374830]
37 De Ribaupierre S, Delalande O. Hemispherotomy and other 
disconnective techniques. Neurosurg Focus 2008; 25: E14 [PMID: 
18759615 DOI: 10.3171/FOC/2008/25/9/E14]
38 Rosenfeld JV, Freeman JL, Harvey AS. Operative technique: the 
anterior transcallosal transseptal interforniceal approach to the 
third ventricle and resection of hypothalamic hamartomas. J Clin 
Neurosci 2004; 11: 738-744 [PMID: 15337137 DOI: 10.1016/
j.jocn.2004.03.008]
39 Freeman JL, Harvey AS, Rosenfeld JV, Wrennall JA, Bailey CA, 
Berkovic SF. Generalized epilepsy in hypothalamic hamartoma: 
evolution and postoperative resolution. Neurology 2003; 60: 
762-767 [PMID: 12629230]
40 Feiz-Erfan I, Horn EM, Rekate HL, Spetzler RF, Ng YT, 
Rosenfeld JV, Kerrigan JF. Surgical strategies for approaching 
hypothalamic hamartomas causing gelastic seizures in the pediatric 
population: transventricular compared with skull base approaches. 
J Neurosurg 2005; 103: 325-332 [PMID: 16270684 DOI: 10.3171/
ped.2005.103.4.0325]
41 Luo S, Li C, Ma Z, Zhang Y, Jia G, Cheng Y. Microsurgical 
treatment for hypothalamic hamartoma in children with precocious 
puberty. Surg Neurol 2002; 57: 356-362; discussion 362 [PMID: 
12128318]
42 Harvey AS, Freeman JL, Berkovic SF, Rosenfeld JV. Transcallosal 
resection of hypothalamic hamartomas in patients with intractable 
epilepsy. Epileptic Disord 2003; 5: 257-265 [PMID: 14975795]
43 Ng YT, Rekate HL, Prenger EC, Chung SS, Feiz-Erfan I, 
Wang NC, Varland MR, Kerrigan JF. Transcallosal resection of 
hypothalamic hamartoma for intractable epilepsy. Epilepsia 2006; 
47: 1192-1202 [PMID: 16886983 DOI: 10.1111/j.1528-1167.2006.
00516.x]
44 Lemole GM, Henn JS, Zabramski JM, Spetzler RF. Modifications 
to the orbitozygomatic approach. Technical note. J Neurosurg 2003; 
99: 924-930 [PMID: 14609176 DOI: 10.3171/jns.2003.99.5.0924]
45 Zabramski JM, Kiriş T, Sankhla SK, Cabiol J, Spetzler RF. 
Orbitozygomatic craniotomy. Technical note. J Neurosurg 1998; 
89: 336-341 [PMID: 9688133 DOI: 10.3171/jns.1998.89.2.0336]
46 Wethe JV, Prigatano GP, Gray J, Chapple K, Rekate HL, Kerrigan 
JF. Cognitive functioning before and after surgical resection for 
hypothalamic hamartoma and epilepsy. Neurology 2013; 81: 1044-1050 
[PMID: 23946307 DOI: 10.1212/WNL.0b013e3182a4a3e3]
47 Régis J, Scavarda D, Tamura M, Nagayi M, Villeneuve N, 
Bartolomei F, Brue T, Dafonseca D, Chauvel P. Epilepsy related 
to hypothalamic hamartomas: surgical management with special 
reference to gamma knife surgery. Childs Nerv Syst 2006; 22: 
881-895 [PMID: 16807727 DOI: 10.1007/s00381-006-0139-y]
48 Li CD, Luo SQ, Tang J, Jia G, Ma ZY, Zhang YQ. Classification 
of hypothalamic hamartoma and prognostic factors for surgical 
outcome. Acta Neurol Scand 2014; 130: 18-26 [PMID: 24382157 
DOI: 10.1111/ane.12209]
49 Schulze-Bonhage A, Homberg V, Trippel M, Keimer R, Elger CE, 
Warnke PC, Ostertag C. Interstitial radiosurgery in the treatment 
of gelastic epilepsy due to hypothalamic hamartomas. Neurology 
2004; 62: 644-647 [PMID: 14981188]
50 Abla AA, Shetter AG, Chang SW, Wait SD, Brachman DG, Ng YT, 
Rekate HL, Kerrigan JF. Gamma Knife surgery for hypothalamic 
hamartomas and epilepsy: patient selection and outcomes. J 
Neurosurg 2010; 113 Suppl: 207-214 [PMID: 21121803]
51 Barajas MA, Ramírez-Guzman MG, Rodríguez-Vázquez C, Toledo-
Buenrostro V, Cuevas-Solórzano A, Rodríguez-Hernández G. 
Gamma knife surgery for hypothalamic hamartomas accompanied 
by medically intractable epilepsy and precocious puberty: 
experience in Mexico. J Neurosurg 2005; 102 Suppl: 53-55 [PMID: 
15662781]
52 Drees C, Chapman K, Prenger E, Baxter L, Maganti R, Rekate 
H, Shetter A, Bobrowitz M, Kerrigan JF. Seizure outcome and 
complications following hypothalamic hamartoma treatment 
in adults: endoscopic, open, and Gamma Knife procedures. J 
Neurosurg 2012; 117: 255-261 [PMID: 22680243 DOI: 10.3171/2
012.5.JNS112256]
53 Dunoyer C, Ragheb J, Resnick T, Alvarez L, Jayakar P, Altman N, 
Wolf A, Duchowny M. The use of stereotactic radiosurgery to treat 
intractable childhood partial epilepsy. Epilepsia 2002; 43: 292-300 
[PMID: 11906515]
54 Kida Y, Yoshimoto M, Hasegawa T. [Radiosurgery of hypothalamic 
hamartomas]. No Shinkei Geka 2008; 36: 225-232 [PMID: 
18341011]
55 Mathieu D, Kondziolka D, Niranjan A, Flickinger J, Lunsford 
LD. Gamma knife radiosurgery for refractory epilepsy caused by 
hypothalamic hamartomas. Stereotact Funct Neurosurg 2006; 84: 
82-87 [PMID: 16790990 DOI: 10.1159/000094036]
56 Unger F, Schröttner O, Feichtinger M, Bone G, Haselsberger K, 
Sutter B. Stereotactic radiosurgery for hypothalamic hamartomas. 
Acta Neurochir Suppl 2002; 84: 57-63 [PMID: 12379005]
57 Régis J, Arkha Y, Yomo S, Bartolomei F, Peragut JC, Chauvel P. 
[Radiosurgery for drug-resistant epilepsies: state of the art, results 
and perspectives]. Neurochirurgie 2008; 54: 320-331 [PMID: 
18417166 DOI: 10.1016/j.neuchi.2008.02.016]
58 Romanelli P, Muacevic A, Striano S. Radiosurgery for hypothalamic 
hamartomas. Neurosurg Focus 2008; 24: E9 [PMID: 18447748 DOI: 
10.3171/FOC/2008/24/5/E9]
59 Quigg M, Barbaro NM. Stereotactic radiosurgery for treatment of 
epilepsy. Arch Neurol 2008; 65: 177-183 [PMID: 18268185 DOI: 
10.1001/archneurol.2007.40]
60 Mittal S, Mittal M, Montes JL, Farmer JP, Andermann F. 
Hypothalamic hamartomas. Part 2. Surgical considerations and 
outcome. Neurosurg Focus 2013; 34: E7 [PMID: 23724841 DOI: 
10.3171/2013.3.FOCUS1356]
61 Fukuda M, Kameyama S, Wachi M, Tanaka R. Stereotaxy for 
hypothalamic hamartoma with intractable gelastic seizures: 
technical case report Neurosurgery 1999; 44: 1347-1350 [PMID: 
10371639]
73 March 28, 2015|Volume 5|Issue 1|WJSP|www.wjgnet.com
Shim KW et al . How would we deal with hypothalamic hamartomas?
62 Kameyama S, Murakami H, Masuda H, Sugiyama I. Minimally 
invasive magnetic resonance imaging-guided stereotactic 
radiofrequency thermocoagulation for epileptogenic hypothalamic 
hamartomas. Neurosurgery 2009; 65: 438-449; discussion 449 
[PMID: 19687687 DOI: 10.1227/01.NEU.0000348292.39252.B5]
63 Homma J, Kameyama S, Masuda H, Ueno T, Fujimoto A, Oishi 
M, Fukuda M. Stereotactic radiofrequency thermocoagulation 
for hypothalamic hamartoma with intractable gelastic seizures. 
Epilepsy Res 2007; 76: 15-21 [PMID: 17643965 DOI: 10.1016/
j.eplepsyres.2007.06.007]
64 Fujimoto Y, Kato A, Saitoh Y, Ninomiya H, Imai K, Hashimoto 
N, Kishima H, Maruno M, Yoshimine T. Open radiofrequency 
ablation for the management of intractable epilepsy associated with 
sessile hypothalamic hamartoma. Minim Invasive Neurosurg 2005; 
48: 132-135 [PMID: 16015488 DOI: 10.1055/s-2004-830267]
65 Parrent AG. Stereotactic radiofrequency ablation for the treatment 
of gelastic seizures associated with hypothalamic hamartoma. Case 
report. J Neurosurg 1999; 91: 881-884 [PMID: 10541251 DOI: 
10.3171/jns.1999.91.5.0881]
66 Khan S, Wright I, Javed S, Sharples P, Jardine P, Carter M, Gill 
SS. High frequency stimulation of the mamillothalamic tract for 
the treatment of resistant seizures associated with hypothalamic 
hamartoma. Epilepsia 2009; 50: 1608-1611 [PMID: 19243422 
DOI: 10.1111/j.1528-1167.2008.01995.x]
67 Marras CE, Rizzi M, Villani F, Messina G, Deleo F, Cordella 
R, Franzini A. Deep brain stimulation for the treatment of drug-
refractory epilepsy in a patient with a hypothalamic hamartoma. 
Case report. Neurosurg Focus 2011; 30: E4 [PMID: 21284450 DOI: 
10.3171/2010.11.FOCUS10241]
68 Murphy JV, Wheless JW, Schmoll CM. Left vagal nerve 
stimulation in six patients with hypothalamic hamartomas. Pediatr 
Neurol 2000; 23: 167-168 [PMID: 11020644]
69 Brandberg G, Raininko R, Eeg-Olofsson O. Hypothalamic 
hamartoma with gelastic seizures in Swedish children and 
adolescents. Eur J Paediatr Neurol 2004; 8: 35-44 [PMID: 15023373 
DOI: 10.1016/j.ejpn.2003.10.003]
P- Reviewer: Sarica FB    S- Editor: Ji FF 
L- Editor: A    E- Editor: Liu SQ 
74 March 28, 2015|Volume 5|Issue 1|WJSP|www.wjgnet.com
Shim KW et al . How would we deal with hypothalamic hamartomas?
                                      © 2015 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
